Evaluating the Use of Antibody Variable Region (Fv) Charge as a Risk Assessment Tool for Predicting Typical Cynomolgus Monkey Pharmacokinetics
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluating the Use of Antibody Variable Region (Fv) Charge as a Risk Assessment Tool for Predicting Typical Cynomolgus Monkey Pharmacokinetics
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 290, Issue 50, Pages 29732-29741
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2015-10-22
DOI
10.1074/jbc.m115.692434
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics
- (2015) Angela Schoch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Incorporating target-mediated drug disposition in a minimal physiologically-based pharmacokinetic model for monoclonal antibodies
- (2014) Yanguang Cao et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule charge
- (2014) Bing Li et al. mAbs
- Clinical development success rates for investigational drugs
- (2014) Michael Hay et al. NATURE BIOTECHNOLOGY
- In silico selection of therapeutic antibodies for development: Viscosity, clearance, and chemical stability
- (2014) Vikas K. Sharma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glycan Shifting on Hepatitis C Virus (HCV) E2 Glycoprotein Is a Mechanism for Escape from Broadly Neutralizing Antibodies
- (2013) Homer Pantua et al. JOURNAL OF MOLECULAR BIOLOGY
- Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity
- (2013) Zenjiro Sampei et al. PLoS One
- Dimerization of LT R by LT 1 2 is necessary and sufficient for signal transduction
- (2013) J. Sudhamsu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Unexpected Thrombocytopenia and Anemia in Cynomolgus Monkeys Induced by a Therapeutic Human Monoclonal Antibody
- (2013) Nancy Everds et al. TOXICOLOGIC PATHOLOGY
- Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
- (2012) Narendra Chirmule et al. AAPS Journal
- Mechanistic Determinants of Biotherapeutics Absorption Following SC Administration
- (2012) Wolfgang F. Richter et al. AAPS Journal
- Physiochemical and Biochemical Factors Influencing the Pharmacokinetics of Antibody Therapeutics
- (2012) Daniela Bumbaca et al. AAPS Journal
- Pharmacokinetic and Pharmacodynamic Analysis of Circulating Biomarkers of Anti-NRP1, a Novel Antiangiogenesis Agent, in Two Phase I Trials in Patients with Advanced Solid Tumors
- (2012) Y. Xin et al. CLINICAL CANCER RESEARCH
- A strategy for risk mitigation of antibodies with fast clearance
- (2012) Isidro Hötzel et al. mAbs
- Marketed therapeutic antibodies compendium
- (2012) Janice M. Reichert mAbs
- In Vivo Depletion of Lymphotoxin-Alpha Expressing Lymphocytes Inhibits Xenogeneic Graft-versus-Host-Disease
- (2012) Eugene Y. Chiang et al. PLoS One
- Off-Target Platelet Activation in Macaques Unique to a Therapeutic Monoclonal Antibody
- (2012) Michael J. Santostefano et al. TOXICOLOGIC PATHOLOGY
- Quantitative Prediction of Human Pharmacokinetics for Monoclonal Antibodies
- (2011) Jennifer Q. Dong et al. CLINICAL PHARMACOKINETICS
- Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4
- (2011) Daniela Bumbaca et al. mAbs
- Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data
- (2011) Rong Deng et al. mAbs
- Complex Pharmacokinetics of a Humanized Antibody Against Human Amyloid Beta Peptide, Anti-Abeta Ab2, in Nonclinical Species
- (2011) Yulia Vugmeyster et al. PHARMACEUTICAL RESEARCH
- Effects of Charge on Antibody Tissue Distribution and Pharmacokinetics
- (2010) C. Andrew Boswell et al. BIOCONJUGATE CHEMISTRY
- Properties of a general PK/PD model of antibody-ligand interactions for therapeutic antibodies that bind to soluble endogenous targets
- (2010) Jasmine P. Davda et al. mAbs
- Reduced elimination of IgG antibodies by engineering the variable region
- (2010) T. Igawa et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Biodistribution Mechanisms of Therapeutic Monoclonal Antibodies in Health and Disease
- (2009) Mohammad Tabrizi et al. AAPS Journal
- CNS Delivery Via Adsorptive Transcytosis
- (2008) Françoise Hervé et al. AAPS Journal
- Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
- (2008) W Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation